Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy of SBR759 compared to sevelamer HCl in lowering serum
phosphate levels in Chronic Kidney Disease patients on hemodialysis